Evaluation and characterisation of novel glucagon receptor antagonists for type 2 diabetes therapy

Evaluation and characterisation of novel glucagon receptor antagonists for type 2 diabetes therapy

Glucagon receptor antagonism is becoming a key target area for type 2 diabetes treatment. This thesis evaluates the potential of novel peptide-based glucagon receptor analogues for type 2 diabetes therapy. Structural modifications of the well established glucagon analogue, desHis1Glu9-glucagon, was...

Full description

Bibliographic Details
Main Author:	Franklin, Zara Jane
Published:	University of Ulster 2012
Subjects:	616.46206
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.588499

Similar Items

Development and evaluation of an intelligent handheld insulin dose advisor for patients with Type 1 diabetes
by: Poerschke, Christine
Published: (2004)

The management of type 2 diabetes
by: Scott, Sarah R.
Published: (2003)

Studies of insulin treatment in the management of type 2 diabetes
by: Dashora, Umesh Kumar
Published: (2006)

Patient-centred study of self-management of diabetes type 2
by: Gomersall, Timothy Philip
Published: (2012)

Assessment and modification of microvascular function in subjects with type 2 diabetes
by: Fegan, Peter Gerard
Published: (2005)

The assessment and management of glycaemic control and vascular risk in people with type 1 diabetes
by: Wallymahmed, Maureen Elizabeth
Published: (2012)

Immunogenicity, efficiency and transcriptional regulation of plasmin-mediated muscle-targeted insulin gene therapy for diabetes
by: Ratanamart, Jarupa
Published: (2006)

The generation, characterisation and potential immunogenicity of insulin producing cell clusters derived from mouse embryonic stem cells
by: Boyd, Ashleigh S.
Published: (2006)

The physiology and treatment of monogenic diabetes
by: Pearson, Ewan Robert
Published: (2005)

Relationships between different measures of glycaemia and their relevance to diabetic complications
by: Kim, Ji-in
Published: (2006)

Healing and Preventing the Diabetic Foot Wound : a marriage of technology and common-sense
by: Armstrong, David G.
Published: (2009)

Investigation of troglitazone hepatoxicity by a metabolomics approach
by: Hong, Mary Khoo Gaik
Published: (2012)

Studies on selected Malaysian plants as antidiabetic agents
by: Ali, Hasenah
Published: (2005)

Differentiation of human embryonic stem cells to the pancreatic lineage
by: Murad, Nadia Yousif
Published: (2008)

Transplantation of pancreatic islet in an immunoisolation device
by: Cornolti, Roberta
Published: (2009)

Effects of dietary stresses and antidiabetic agents on pancreatic Î²-cell function
by: Richardson, Hannah
Published: (2006)

Expert patient education versus routine treatment : X-PERT
by: Deaken, Trudi Anne
Published: (2004)

The potential of novel glucagon receptor antagonists alone and in combination with other peptides for the treatment of diabetes
by: McShane, Laura Majella
Published: (2013)

Pro-glucagon derived peptide therapies for type 2 diabetes and obesity
by: Bhat, Kattathila Vikas
Published: (2014)

Investigating the production of secondary metabolites effective in lowering blood glucose levels in Euclea Undulata Thunb. Var Myrtina (Ebenaceae)
by: Botha, Lynette Elizabeth
Published: (2017)

Investigation of the antidiabetic actions and function of insulin, glucagon and glucagon-like peptide 1 secreting cells for transplantation therapy of diabetes
by: Green, Alastair David
Published: (2015)

G-protein coupled receptors expressed by islet cells modulate glucagon as well as insulin secretion in type 2 diabetes
by: Gormley, Noella Marie
Published: (2016)

Characterisation of cyclic nucleotide phosphodiesterases in the glucagon-like peptide-1-secreting GLUTag cell line
by: Ong, Wee Kiat
Published: (2008)

Development and characterisation of novel proglucagon-derived peptide analogues for the treatment of Type 2 diabetes
by: Lynch, Aisling Martina
Published: (2013)

Type II diabetes and the pancreatic B cell : molecular characterisation of ion channel and transporter polymorphisms
by: Nicolson, Tamara Jane
Published: (2010)

Novel incretin based therapies for type 2 diabetes and obesity
by: Kerr, Barry
Published: (2011)

Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonist.
by: James Mu, et al.
Published: (2012-01-01)

Lipid anchored truncated cytokine receptor antagonists
by: Gavalas, Nikolaos
Published: (2004)

Development and assessment of a leptin receptor antagonist
by: Fazeli, Mehdi
Published: (2005)

Experimental studies in the pathology of diabetes mellitus, with particular reference to glucagon as a second pancreatic hormone
by: Peden, Alexander Stewart Campbell
Published: (1954)

Investigation of the effects of the glucagon-like peptide-1 mimetic exendin-4 on cardiac remodelling in diabetes
by: Tate, Mitchel
Published: (2015)

Identification and characterisation of novel mechanisms that regulate TRAIL-receptor signalling complexes
by: Peall, Adam
Published: (2017)

Characterisation of the C-type lectin receptor CLEC-2 : expression, ligands and functions
by: Souto Maior Mourão Sá, D.
Published: (2011)

Novel kappa opioid receptor antagonists : an investigation of the duration of action and role in depression and anxiety-related behaviours
by: Dominguez, Joseph Casal
Published: (2011)

Characterisation of novel nociceptive mechanisms during persistent inflammation
by: Inglis, Julia Jane
Published: (2003)

Glucagon in hyperandrogenic women : relationships to abnormalities of insulin
by: Golland, Ian Morris
Published: (1992)

Characterisation of a novel receptor for IgA expressed by human mesangial cells
by: Barratt, Jonathan
Published: (2001)

Characterisation of the Transcriptional regulation of the genetic variants of the receptor for advanced glycation end-products
by: Dolling, Sarah Jane
Published: (2005)

Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice
by: Rui Wei, et al.
Published: (2019-06-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)